Healthcare >> CEO Interviews >> May 27, 2003
ROGER G. HARRISON joined Antares Pharma, Inc., as Chief Executive
Officer, President and a member of the Board of Directors in March 2001.
From 1984, Dr. Harrison held various positions at Eli Lilly and Company,
with his most recent role being Director of Alliance Management from May
1999 until March 2001. Other positions at Eli Lilly and Company included
Global Product Team Leader from March 1997 to May 1999 and Director,
Development Projects Management and Technology Development and Planning
from September 1993 to May 1997. He is the author of 12 publications,
has contributed to four books and holds nine patents. Dr. Harrison
earned a PhD in organic chemistry and a BSc in Chemistry from Leeds
University in the United Kingdom and conducted postdoctoral research
work at Zurich University in Switzerland. Profile
Dr. Harrison: Antares Pharma is a small drug delivery company
with facilities in Basel, Switzerland; Minneapolis, Minnesota;
and
